Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

,921 Amortization of licensing costs 11,755 1,472 1,472 Amortization of property and equipment 517 125 134 Loss on disposal of property and equipment 11 11 - ------------ -------- -------- (118,881) 3,343 (43,681) Net change in non-cash working capital items Goods and services tax recoverable (299) 185 (28) Prepaid and other current assets (2,548) 734 (571) Advanced clinical trial costs (790) 1,186 (1,976) Accounts payable and accrued liabilities 9,151 (601) 933 Deferred revenue 45,605 45,605 - ------------ -------- -------- (67,762) 50,452 (45,323) ------------ -------- -------- Investing activities Purchase of property and equipment (1,045) (323) (109) Net (purchase of) proceeds from short-term investments (2,614) (86) 3,149 Licensing costs (6,467) - - ------------ -------- -------- (10,126) (409) 3,040 ------------ -------- -------- Financing activities Proceeds from issuance of share capital 178,729 91 44,512 Repurchase of share capital (3,552) (1,434) (36) Share issue costs (12,312) - (3,332)
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Scotland , July 2, 2015 ... Bio-tech procurement company Amici Procurement has chosen ... to help it move to Office 365. ... provides small to medium-sized companies in the bio-tech ... all aspects of the purchasing cycle to help them ...
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... , July 1, 2015 Isagenix International, a ... earned three Gold, three Silver, and three Bronze Stevie® ... held in Chicago this month.The ... premier business awards program in the U.S. ... company,s strength in developing leaders, cultivating talent, creating a ...
(Date:7/1/2015)... , July 1, 2015  UCB, a ... ), a global leader in designing, transforming, and ... Innovation Award in recognition of their close collaboration ... in UCB,s global business services (GBS) finance organization. ... providers and clients that work together effectively to ...
Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5
... 1 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX:ONY) ... investigational new,drug (IND) application with the U.S. ... molecule phosphatidylinositol-3-kinase (PI-3-kinase),inhibitor for the treatment of ... initiate a Phase 1 clinical trial of ...
... DIEGO, April 30 BioMed Realty Trust, Inc.,(NYSE: ... ten-year lease for more,than 140,000 square feet at the ... Technologies, Inc.,(Nasdaq: DSTI ) will join BioMed,s rapidly ... the East Bay of San Francisco,s thriving,technology corridor., ...
... isnt always easy. However, shaking the bottle before trying to ... because it becomes more fluid when agitated. The opposite is ... not become a gel when shaken. , However, new ... Physical Review Letters shows that when fluids like water and ...
Cached Biology Technology:Oncothyreon files investigational new drug application for PX-866 oncology compound 2Oncothyreon files investigational new drug application for PX-866 oncology compound 3BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center 2BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center 3Atomic force microscopy reveals liquids adjust viscosity when confined, shaken 2Atomic force microscopy reveals liquids adjust viscosity when confined, shaken 3
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... Raffa, a professor at the University of Wisconsin Department of ... lecture at Entomology 2010 the 58th Annual Meeting of ... San Diego, California. The honoree is the late Dr. Andrew ... 1958 to honor scientists whose lives and careers enhanced entomology ...
... once abundant in the Rocky Mountains and Great Plains, ... a virulent bacterial disease spread by fleas. Plague ... thousands of inhabitants, killing virtually the entire population within ... new colony, which eventually is wiped out when the ...
... fructose, very common in the Western diet, to activate a ... to grow more quickly, a study by researchers at UCLA,s ... known that cancers use glucose, a simple sugar, to fuel ... been shown between fructose and cancer proliferation, said Dr. Anthony ...
Cached Biology News:Kenneth F. Raffa to give Founders' Memorial Lecture at Entomology 2010 2Carnivorous mice spread deadly plague in prairie dog towns, Stanford study finds 2Carnivorous mice spread deadly plague in prairie dog towns, Stanford study finds 3Carnivorous mice spread deadly plague in prairie dog towns, Stanford study finds 4Pancreatic cancers use fructose, common in the Western diet, to fuel their growth 2Pancreatic cancers use fructose, common in the Western diet, to fuel their growth 3